Join our collaborators at OncobitesTv for an interview featuring @DrCrisPadua as he shares research on larotrectinib as an effective tx for TRK fusion #BreastCancer straight out of
#SABCS24
Link to view: buff.ly/3CpGyc8
with Dr. @elisaagostinetto.bsky.social from Jules Bordet Institut
#SABCS24
Link to view: buff.ly/3CpGyc8
with Dr. @elisaagostinetto.bsky.social from Jules Bordet Institut
January 21, 2025 at 12:15 PM
Join our collaborators at OncobitesTv for an interview featuring @DrCrisPadua as he shares research on larotrectinib as an effective tx for TRK fusion #BreastCancer straight out of
#SABCS24
Link to view: buff.ly/3CpGyc8
with Dr. @elisaagostinetto.bsky.social from Jules Bordet Institut
#SABCS24
Link to view: buff.ly/3CpGyc8
with Dr. @elisaagostinetto.bsky.social from Jules Bordet Institut
Join our collaborators at @OncobitesTv for an interview featuring @DrCrisPadua as he shares research on larotrectinib as an effective tx for TRK fusion #BreastCancer #SABCS24
https://buff.ly/4iSMoU6
@elisaagostinetto.bsky.social interviews Dr. Souza, discussing safety and impact of this therapy
https://buff.ly/4iSMoU6
@elisaagostinetto.bsky.social interviews Dr. Souza, discussing safety and impact of this therapy
SABCS24 ONCOALERT | ONCOBITES
Oncobites
buff.ly
January 7, 2025 at 11:54 AM
Join our collaborators at @OncobitesTv for an interview featuring @DrCrisPadua as he shares research on larotrectinib as an effective tx for TRK fusion #BreastCancer #SABCS24
https://buff.ly/4iSMoU6
@elisaagostinetto.bsky.social interviews Dr. Souza, discussing safety and impact of this therapy
https://buff.ly/4iSMoU6
@elisaagostinetto.bsky.social interviews Dr. Souza, discussing safety and impact of this therapy
CDK4/6inh and ADC therapy for HER2+ #BreastCancer (FASCINATE & PATINA)
Brought to you by high5md & OncoAlert straight from #SABCS24
Join Moderators Nadia Harbeck, Wolfgang Janni
and Expert Panel of: Barbara Pistilli, , Peter Fasching, Michael Untch & Diana Luftner
youtu.be/ShNgvoW_264?...
Brought to you by high5md & OncoAlert straight from #SABCS24
Join Moderators Nadia Harbeck, Wolfgang Janni
and Expert Panel of: Barbara Pistilli, , Peter Fasching, Michael Untch & Diana Luftner
youtu.be/ShNgvoW_264?...
Disussion on the FASCINATE & PATINA Trials in Breast Cancer straight from SABCS24
YouTube video by OncoAlert 360
youtu.be
January 6, 2025 at 12:49 PM
CDK4/6inh and ADC therapy for HER2+ #BreastCancer (FASCINATE & PATINA)
Brought to you by high5md & OncoAlert straight from #SABCS24
Join Moderators Nadia Harbeck, Wolfgang Janni
and Expert Panel of: Barbara Pistilli, , Peter Fasching, Michael Untch & Diana Luftner
youtu.be/ShNgvoW_264?...
Brought to you by high5md & OncoAlert straight from #SABCS24
Join Moderators Nadia Harbeck, Wolfgang Janni
and Expert Panel of: Barbara Pistilli, , Peter Fasching, Michael Untch & Diana Luftner
youtu.be/ShNgvoW_264?...
Join OncobitesTv for an interview featuring @DrCrisPadua as he shares research on larotrectinib as an effective tx for TRK fusion #BreastCancer #SABCS24
Link to view: https://buff.ly/4iSMoU6
Dr. @elisaagostinetto.bsky.social interviews Dr. Souza, discussing the safety and impact of this therapy.
Link to view: https://buff.ly/4iSMoU6
Dr. @elisaagostinetto.bsky.social interviews Dr. Souza, discussing the safety and impact of this therapy.
January 3, 2025 at 10:00 AM
Join OncobitesTv for an interview featuring @DrCrisPadua as he shares research on larotrectinib as an effective tx for TRK fusion #BreastCancer #SABCS24
Link to view: https://buff.ly/4iSMoU6
Dr. @elisaagostinetto.bsky.social interviews Dr. Souza, discussing the safety and impact of this therapy.
Link to view: https://buff.ly/4iSMoU6
Dr. @elisaagostinetto.bsky.social interviews Dr. Souza, discussing the safety and impact of this therapy.
An honor🚨to partner up with our friends at high5md for these discussions during #SABCS24 on CDK4/6inh and ADC therapy for HER2+ Breast Cancer
Join Moderators
Nadia Harbeck 🇩🇪
Wolfgang Janni 🇩🇪
Expert Panel
Barbara pistilli🇫🇷
Peter Fasching 🇩🇪
Michael Untch 🇩🇪
Diana Lüftner 🇩🇪
youtu.be/ShNgvoW_264?...
Join Moderators
Nadia Harbeck 🇩🇪
Wolfgang Janni 🇩🇪
Expert Panel
Barbara pistilli🇫🇷
Peter Fasching 🇩🇪
Michael Untch 🇩🇪
Diana Lüftner 🇩🇪
youtu.be/ShNgvoW_264?...
Disussion on the FASCINATE & PATINA Trials in Breast Cancer straight from SABCS24
YouTube video by OncoAlert 360
youtu.be
January 2, 2025 at 10:48 AM
An honor🚨to partner up with our friends at high5md for these discussions during #SABCS24 on CDK4/6inh and ADC therapy for HER2+ Breast Cancer
Join Moderators
Nadia Harbeck 🇩🇪
Wolfgang Janni 🇩🇪
Expert Panel
Barbara pistilli🇫🇷
Peter Fasching 🇩🇪
Michael Untch 🇩🇪
Diana Lüftner 🇩🇪
youtu.be/ShNgvoW_264?...
Join Moderators
Nadia Harbeck 🇩🇪
Wolfgang Janni 🇩🇪
Expert Panel
Barbara pistilli🇫🇷
Peter Fasching 🇩🇪
Michael Untch 🇩🇪
Diana Lüftner 🇩🇪
youtu.be/ShNgvoW_264?...
Join our collaborators at @high5md for all the #BreastCancer updates from #SABCS24 featuring insights from some of the world’s leading international breast cancer experts.
Visit them at:
https://buff.ly/49Dc42Q
Visit them at:
https://buff.ly/49Dc42Q
December 23, 2024 at 2:37 PM
Join our collaborators at @high5md for all the #BreastCancer updates from #SABCS24 featuring insights from some of the world’s leading international breast cancer experts.
Visit them at:
https://buff.ly/49Dc42Q
Visit them at:
https://buff.ly/49Dc42Q
The NeoMono trial #SABCS24
neoadjuvant study inTNBC, the trial’s unique design and high rates of PCR, especially among PD-L1 + patients, no significant treatment interaction
Report with Hans-Christian Kolberg (VJ Onc)
neoadjuvant study inTNBC, the trial’s unique design and high rates of PCR, especially among PD-L1 + patients, no significant treatment interaction
Report with Hans-Christian Kolberg (VJ Onc)
Subgroup analysis from NeoMono: PD-L1 status and pCR in high-risk eTNBC - VJOncology
Hans-Christian Kolberg, MD, Marienhospital Bottrop, Bottrop, Germany, comments on the results of the NeoMono trial, a Phase II neoadjuvant randomized...
bit.ly
December 18, 2024 at 2:53 PM
The NeoMono trial #SABCS24
neoadjuvant study inTNBC, the trial’s unique design and high rates of PCR, especially among PD-L1 + patients, no significant treatment interaction
Report with Hans-Christian Kolberg (VJ Onc)
neoadjuvant study inTNBC, the trial’s unique design and high rates of PCR, especially among PD-L1 + patients, no significant treatment interaction
Report with Hans-Christian Kolberg (VJ Onc)
EMBER3 Presented at #SABCS24
Imlunestrant, a novel oral medication, significantly improved progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer, especially those with ESR1 mutations.
Report with Peter Fasching
(high5 Onc)
https://buff.ly/3OZdxXF
Imlunestrant, a novel oral medication, significantly improved progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer, especially those with ESR1 mutations.
Report with Peter Fasching
(high5 Onc)
https://buff.ly/3OZdxXF
December 18, 2024 at 2:37 PM
EMBER3 Presented at #SABCS24
Imlunestrant, a novel oral medication, significantly improved progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer, especially those with ESR1 mutations.
Report with Peter Fasching
(high5 Onc)
https://buff.ly/3OZdxXF
Imlunestrant, a novel oral medication, significantly improved progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer, especially those with ESR1 mutations.
Report with Peter Fasching
(high5 Onc)
https://buff.ly/3OZdxXF
Coming Soon
@high5md & @OncoAlert 🚨
Straight out of #SABCS24
Nadia Harbeck
@hoperugo.bsky.social
Barbara Pistilli
and many more........Stay Tuned
#BreastCancer
@high5md & @OncoAlert 🚨
Straight out of #SABCS24
Nadia Harbeck
@hoperugo.bsky.social
Barbara Pistilli
and many more........Stay Tuned
#BreastCancer
December 17, 2024 at 4:29 PM
Coming Soon
@high5md & @OncoAlert 🚨
Straight out of #SABCS24
Nadia Harbeck
@hoperugo.bsky.social
Barbara Pistilli
and many more........Stay Tuned
#BreastCancer
@high5md & @OncoAlert 🚨
Straight out of #SABCS24
Nadia Harbeck
@hoperugo.bsky.social
Barbara Pistilli
and many more........Stay Tuned
#BreastCancer
PADMA presented at #SABCS24 showed that palbociclib + ET improves time to treatment failure and PFS compared to chemotherapy in high-risk HR+/HER2- metastatic breast cancer, supporting use as the standard 1st L tx
Report with Alessandra Gennari (high5 Onc)
Report with Alessandra Gennari (high5 Onc)
High5 Oncology TV: SABCS 2024
61/ 64 videos online
buff.ly
December 17, 2024 at 2:00 PM
PADMA presented at #SABCS24 showed that palbociclib + ET improves time to treatment failure and PFS compared to chemotherapy in high-risk HR+/HER2- metastatic breast cancer, supporting use as the standard 1st L tx
Report with Alessandra Gennari (high5 Onc)
Report with Alessandra Gennari (high5 Onc)
OUR COMPLETE #SABCS24 🚨Newsletter IS OUT
REGISTER at oncoalert360.com OR buff.ly/48Xpgz0
This Includes all of OUR TOP pick of TRIALS presented during these last 4 days in San Antonio & Video Interviews from our Collaborators at @vjoncology.bsky.social and high5md
REGISTER at oncoalert360.com OR buff.ly/48Xpgz0
This Includes all of OUR TOP pick of TRIALS presented during these last 4 days in San Antonio & Video Interviews from our Collaborators at @vjoncology.bsky.social and high5md
December 16, 2024 at 5:00 PM
OUR COMPLETE #SABCS24 🚨Newsletter IS OUT
REGISTER at oncoalert360.com OR buff.ly/48Xpgz0
This Includes all of OUR TOP pick of TRIALS presented during these last 4 days in San Antonio & Video Interviews from our Collaborators at @vjoncology.bsky.social and high5md
REGISTER at oncoalert360.com OR buff.ly/48Xpgz0
This Includes all of OUR TOP pick of TRIALS presented during these last 4 days in San Antonio & Video Interviews from our Collaborators at @vjoncology.bsky.social and high5md
Dear Colleagues,
Thank you for joining Us in our Home of San Antonio Tx for yet another amazing #SABCS24
OncoAlert 🚨 would like to thank some if its faculty for the amazing coverage during the last 5 days. We thank everyone that contributed but wanted to give a special shout Out
Thank you for joining Us in our Home of San Antonio Tx for yet another amazing #SABCS24
OncoAlert 🚨 would like to thank some if its faculty for the amazing coverage during the last 5 days. We thank everyone that contributed but wanted to give a special shout Out
December 14, 2024 at 3:38 PM
Dear Colleagues,
Thank you for joining Us in our Home of San Antonio Tx for yet another amazing #SABCS24
OncoAlert 🚨 would like to thank some if its faculty for the amazing coverage during the last 5 days. We thank everyone that contributed but wanted to give a special shout Out
Thank you for joining Us in our Home of San Antonio Tx for yet another amazing #SABCS24
OncoAlert 🚨 would like to thank some if its faculty for the amazing coverage during the last 5 days. We thank everyone that contributed but wanted to give a special shout Out
Dear Colleagues
An amazing #SABCS24 and our thanks to our collaborators at @SABCSSanAntonio
For yet another amazing Symposium
✅ 70 million impressions
✅ 11.5k posts
✅ 1.7k Participants
WE ARE ALL @OncoAlert 🚨
An amazing #SABCS24 and our thanks to our collaborators at @SABCSSanAntonio
For yet another amazing Symposium
✅ 70 million impressions
✅ 11.5k posts
✅ 1.7k Participants
WE ARE ALL @OncoAlert 🚨
December 14, 2024 at 12:09 AM
Dear Colleagues
An amazing #SABCS24 and our thanks to our collaborators at @SABCSSanAntonio
For yet another amazing Symposium
✅ 70 million impressions
✅ 11.5k posts
✅ 1.7k Participants
WE ARE ALL @OncoAlert 🚨
An amazing #SABCS24 and our thanks to our collaborators at @SABCSSanAntonio
For yet another amazing Symposium
✅ 70 million impressions
✅ 11.5k posts
✅ 1.7k Participants
WE ARE ALL @OncoAlert 🚨
Coming Soon from @high5md & @OncoAlert 🚨
Straight from #SABCS24 🇺🇸
@Prof_Nadia_H
@hoperugo
@BarbaraPistill2
and many more........Stay Tuned
Straight from #SABCS24 🇺🇸
@Prof_Nadia_H
@hoperugo
@BarbaraPistill2
and many more........Stay Tuned
December 13, 2024 at 11:50 PM
Coming Soon from @high5md & @OncoAlert 🚨
Straight from #SABCS24 🇺🇸
@Prof_Nadia_H
@hoperugo
@BarbaraPistill2
and many more........Stay Tuned
Straight from #SABCS24 🇺🇸
@Prof_Nadia_H
@hoperugo
@BarbaraPistill2
and many more........Stay Tuned
Thank you for your support during #SABCS24 ‼️
OUR COMPLETE SABCS24 Newsletter COMES OUT MONDAY NEXT WEEK
REGISTER AT oncoalert360.com OR buff.ly/48Xpgz0
All OUR TOP pick presented during San Antonio
@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@erikahamilton9.bsky.social
OUR COMPLETE SABCS24 Newsletter COMES OUT MONDAY NEXT WEEK
REGISTER AT oncoalert360.com OR buff.ly/48Xpgz0
All OUR TOP pick presented during San Antonio
@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@erikahamilton9.bsky.social
December 13, 2024 at 7:16 PM
Thank you for your support during #SABCS24 ‼️
OUR COMPLETE SABCS24 Newsletter COMES OUT MONDAY NEXT WEEK
REGISTER AT oncoalert360.com OR buff.ly/48Xpgz0
All OUR TOP pick presented during San Antonio
@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@erikahamilton9.bsky.social
OUR COMPLETE SABCS24 Newsletter COMES OUT MONDAY NEXT WEEK
REGISTER AT oncoalert360.com OR buff.ly/48Xpgz0
All OUR TOP pick presented during San Antonio
@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@erikahamilton9.bsky.social
Dear Colleagues at #SABCS24
Join our collaborators at @high5md for the latest #BreastCancer updates directly from San Antonio
Visit them at: https://buff.ly/49Dc42Q
Featuring insights from some of the world’s leading international breast cancer experts
https://buff.ly/49Dc42Q
Join our collaborators at @high5md for the latest #BreastCancer updates directly from San Antonio
Visit them at: https://buff.ly/49Dc42Q
Featuring insights from some of the world’s leading international breast cancer experts
https://buff.ly/49Dc42Q
December 13, 2024 at 6:00 PM
Dear Colleagues at #SABCS24
Join our collaborators at @high5md for the latest #BreastCancer updates directly from San Antonio
Visit them at: https://buff.ly/49Dc42Q
Featuring insights from some of the world’s leading international breast cancer experts
https://buff.ly/49Dc42Q
Join our collaborators at @high5md for the latest #BreastCancer updates directly from San Antonio
Visit them at: https://buff.ly/49Dc42Q
Featuring insights from some of the world’s leading international breast cancer experts
https://buff.ly/49Dc42Q
Colleagues at #SABCS24
Join our collaborators at @mirrorsmed for a webinar on Wednesday, 22 January 2025, from 19:00 to 20:00 CET,
https://buff.ly/4feKcmv
Experts discuss the management of hormone receptor-positive, HER2-negative metastatic #BreastCancer
https://buff.ly/4feKcmv
Join our collaborators at @mirrorsmed for a webinar on Wednesday, 22 January 2025, from 19:00 to 20:00 CET,
https://buff.ly/4feKcmv
Experts discuss the management of hormone receptor-positive, HER2-negative metastatic #BreastCancer
https://buff.ly/4feKcmv
December 13, 2024 at 5:39 PM
Colleagues at #SABCS24
Join our collaborators at @mirrorsmed for a webinar on Wednesday, 22 January 2025, from 19:00 to 20:00 CET,
https://buff.ly/4feKcmv
Experts discuss the management of hormone receptor-positive, HER2-negative metastatic #BreastCancer
https://buff.ly/4feKcmv
Join our collaborators at @mirrorsmed for a webinar on Wednesday, 22 January 2025, from 19:00 to 20:00 CET,
https://buff.ly/4feKcmv
Experts discuss the management of hormone receptor-positive, HER2-negative metastatic #BreastCancer
https://buff.ly/4feKcmv
The OncoAlert🚨 #SABCS24 DAY 3 RoundUp
REGISTER AT https://buff.ly/4eIDeWG OR https://buff.ly/48Xpgz0
✅INSEMA ( @NEJM )
✅EUROPA ( @TheLancetOncol )🇪🇺
✅COMET ( @JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
and more
REGISTER AT https://buff.ly/4eIDeWG OR https://buff.ly/48Xpgz0
✅INSEMA ( @NEJM )
✅EUROPA ( @TheLancetOncol )🇪🇺
✅COMET ( @JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
and more
Day Three Video Round Up of The San Antonio Breast Cancer Symposium 2024
The OncoAlert🚨 #SABCS24 DAY 3 RoundUp REGISTER AT http://OncoAlert360.com OR https://buff.ly/48Xpgz0 ✅INSEMA ✅EUROPA ✅COMET ✅SUPREMO⚖️✅PATINAand more
youtu.be
December 13, 2024 at 5:28 PM
The OncoAlert🚨 #SABCS24 DAY 3 RoundUp
REGISTER AT https://buff.ly/4eIDeWG OR https://buff.ly/48Xpgz0
✅INSEMA ( @NEJM )
✅EUROPA ( @TheLancetOncol )🇪🇺
✅COMET ( @JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
and more
REGISTER AT https://buff.ly/4eIDeWG OR https://buff.ly/48Xpgz0
✅INSEMA ( @NEJM )
✅EUROPA ( @TheLancetOncol )🇪🇺
✅COMET ( @JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
and more
Dear Colleagues at #SABCS24
A pleasure to introduce our @OncoAlert 🚨Faculty Evandro de Azambuja 🇧🇪
OlympiA showed that 1 year of adjuvant olaparib significantly improved survival outcomes in BRCA-positive, HER2-negative breast cancer patients after chemotherapy
A pleasure to introduce our @OncoAlert 🚨Faculty Evandro de Azambuja 🇧🇪
OlympiA showed that 1 year of adjuvant olaparib significantly improved survival outcomes in BRCA-positive, HER2-negative breast cancer patients after chemotherapy
Dr. Evandro de Azambuja Discussing OlympiA Breast Cancer Trial during SABCS24
OlympiAThe OlympiA trial showed that one year of adjuvant olaparib significantly improved survival outcomes in BRCA-positive, HER2-negative breast cancer pat...
buff.ly
December 13, 2024 at 5:25 PM
Dear Colleagues at #SABCS24
A pleasure to introduce our @OncoAlert 🚨Faculty Evandro de Azambuja 🇧🇪
OlympiA showed that 1 year of adjuvant olaparib significantly improved survival outcomes in BRCA-positive, HER2-negative breast cancer patients after chemotherapy
A pleasure to introduce our @OncoAlert 🚨Faculty Evandro de Azambuja 🇧🇪
OlympiA showed that 1 year of adjuvant olaparib significantly improved survival outcomes in BRCA-positive, HER2-negative breast cancer patients after chemotherapy
An Amazing Day 3⃣ at #SABCS24 🇺🇸
Our gratitude to our hosts and Collaborators SABCS for their amazing work‼️
The Stats on X are:
✅54 million IMpressions
✅8,8k Posts
✅Around 1,5k Participants
WE ARE @OncoAlert 🚨
Our gratitude to our hosts and Collaborators SABCS for their amazing work‼️
The Stats on X are:
✅54 million IMpressions
✅8,8k Posts
✅Around 1,5k Participants
WE ARE @OncoAlert 🚨
December 13, 2024 at 4:34 AM
An Amazing Day 3⃣ at #SABCS24 🇺🇸
Our gratitude to our hosts and Collaborators SABCS for their amazing work‼️
The Stats on X are:
✅54 million IMpressions
✅8,8k Posts
✅Around 1,5k Participants
WE ARE @OncoAlert 🚨
Our gratitude to our hosts and Collaborators SABCS for their amazing work‼️
The Stats on X are:
✅54 million IMpressions
✅8,8k Posts
✅Around 1,5k Participants
WE ARE @OncoAlert 🚨
The OncoAlert🚨 #SABCS24 DAY 3 Newsletter
Out tomorrow morning 7am (San Antonio, Tx)
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0
✅INSEMA ( @NEJM )
✅EUROPA (@TheLancetOncol )🇪🇺
✅COMET (@JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
✅SOUND🔊
✅P-Veriry
Out tomorrow morning 7am (San Antonio, Tx)
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0
✅INSEMA ( @NEJM )
✅EUROPA (@TheLancetOncol )🇪🇺
✅COMET (@JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
✅SOUND🔊
✅P-Veriry
December 13, 2024 at 12:31 AM
The OncoAlert🚨 #SABCS24 DAY 3 Newsletter
Out tomorrow morning 7am (San Antonio, Tx)
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0
✅INSEMA ( @NEJM )
✅EUROPA (@TheLancetOncol )🇪🇺
✅COMET (@JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
✅SOUND🔊
✅P-Veriry
Out tomorrow morning 7am (San Antonio, Tx)
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0
✅INSEMA ( @NEJM )
✅EUROPA (@TheLancetOncol )🇪🇺
✅COMET (@JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
✅SOUND🔊
✅P-Veriry
Our Collaborators at @VJOncology are in San Antonio for #SABCS24 bringing you the highly-anticipated trial data and insightful perspectives from leading experts in #BreastCancer
Find their Coverage here: https://bit.ly/48P9tCd
Find their Coverage here: https://bit.ly/48P9tCd
December 12, 2024 at 9:18 PM
Our Collaborators at @VJOncology are in San Antonio for #SABCS24 bringing you the highly-anticipated trial data and insightful perspectives from leading experts in #BreastCancer
Find their Coverage here: https://bit.ly/48P9tCd
Find their Coverage here: https://bit.ly/48P9tCd
Dear Colleagues at #SABCS24
Join our collaborators at @high5md STARTING TOMORROW for the latest #BreastCancer updates directly from San Antonio, featuring insights from some of the world’s leading international breast cancer experts Visit them at: https://buff.ly/3Brk0r9
https://buff.ly/49Dc42Q
Join our collaborators at @high5md STARTING TOMORROW for the latest #BreastCancer updates directly from San Antonio, featuring insights from some of the world’s leading international breast cancer experts Visit them at: https://buff.ly/3Brk0r9
https://buff.ly/49Dc42Q
December 12, 2024 at 9:04 PM
Dear Colleagues at #SABCS24
Join our collaborators at @high5md STARTING TOMORROW for the latest #BreastCancer updates directly from San Antonio, featuring insights from some of the world’s leading international breast cancer experts Visit them at: https://buff.ly/3Brk0r9
https://buff.ly/49Dc42Q
Join our collaborators at @high5md STARTING TOMORROW for the latest #BreastCancer updates directly from San Antonio, featuring insights from some of the world’s leading international breast cancer experts Visit them at: https://buff.ly/3Brk0r9
https://buff.ly/49Dc42Q
Dear Colleagues at #SABCS24
Join our collaborators at @mirrorsmed for a webinar on Wednesday, 22 January 2025, from 19:00 to 20:00 CET, as experts Drs. Brain, de Azambuja, Guarneri, Saura, & Wildiers discuss management of HRr-positive, HER2-negative metastatic #BreastCancer
https://buff.ly/4feKcmv
Join our collaborators at @mirrorsmed for a webinar on Wednesday, 22 January 2025, from 19:00 to 20:00 CET, as experts Drs. Brain, de Azambuja, Guarneri, Saura, & Wildiers discuss management of HRr-positive, HER2-negative metastatic #BreastCancer
https://buff.ly/4feKcmv
December 12, 2024 at 8:55 PM
Dear Colleagues at #SABCS24
Join our collaborators at @mirrorsmed for a webinar on Wednesday, 22 January 2025, from 19:00 to 20:00 CET, as experts Drs. Brain, de Azambuja, Guarneri, Saura, & Wildiers discuss management of HRr-positive, HER2-negative metastatic #BreastCancer
https://buff.ly/4feKcmv
Join our collaborators at @mirrorsmed for a webinar on Wednesday, 22 January 2025, from 19:00 to 20:00 CET, as experts Drs. Brain, de Azambuja, Guarneri, Saura, & Wildiers discuss management of HRr-positive, HER2-negative metastatic #BreastCancer
https://buff.ly/4feKcmv
The OncoAlert🚨 #SABCS24 DAY2 Round Up
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0
Discussing:
✅EMBER3 (Out on @NEJM )
✅Olympia
✅PRO B
✅ePROs
✅SHR-A1811
✅PHILA
✅Risk Reducing Surg in yBC patients w/BRCA mut
https://buff.ly/49xlNaA
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0
Discussing:
✅EMBER3 (Out on @NEJM )
✅Olympia
✅PRO B
✅ePROs
✅SHR-A1811
✅PHILA
✅Risk Reducing Surg in yBC patients w/BRCA mut
https://buff.ly/49xlNaA
Day One Video Round Up of The San Antonio Breast Cancer Symposium 2024
he OncoAlert🚨 #SABCS24 DAY2 Round Up REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0Discussing:✅EMBER3 (Out on @NEJM )✅Olympia✅PRO B✅ePROs✅SH...
youtu.be
December 12, 2024 at 4:15 PM
The OncoAlert🚨 #SABCS24 DAY2 Round Up
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0
Discussing:
✅EMBER3 (Out on @NEJM )
✅Olympia
✅PRO B
✅ePROs
✅SHR-A1811
✅PHILA
✅Risk Reducing Surg in yBC patients w/BRCA mut
https://buff.ly/49xlNaA
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0
Discussing:
✅EMBER3 (Out on @NEJM )
✅Olympia
✅PRO B
✅ePROs
✅SHR-A1811
✅PHILA
✅Risk Reducing Surg in yBC patients w/BRCA mut
https://buff.ly/49xlNaA